Search results
Results from the WOW.Com Content Network
The receipt of the FDA's letter would not impact Viatris' 2024 forecast or its new product revenue range of $450 million to $550 million, the company said. In MS, the immune system attacks brain ...
The statement from Viatris did not mention why Mylan was dropped from the probe. The company said it would continue to defend itself against the remaining civil lawsuits related to the matter.
Novartis and Viatris were hit with a federal lawsuit in Maryland on Monday by the family of a woman whose tissue cells were taken from her body in the 1950s and used to fuel medical research and ...
In April 2023, Viatris was recognized by LinkedIn as one of the 25 best companies to work for in India, [21] and one of the 25 best companies offering career development in Ireland. [22] In May 2023, USA Today included Viatris in its list of 400 US companies that have reduced their greenhouse gas emissions intensity from 2019 to 2021. [23]
However, Viatris posted positive adjusted earnings per share of $0.69, up 3% year over year and topping the average analysts' estimate of $0.68. What investors liked the most about Viatris' Q2 update
ConsumerAffairs is an American customer review and consumer news platform that provides information for purchasing decisions around major life changes or milestones. [5] The company's business-facing division provides SaaS that allows brands to manage and analyze review data to improve their products and customer service.
The complaint alleged price collusion schemes between six pharmaceutical firms including informal gatherings, telephone calls, and text messages. [ 77 ] In October 2017, the company announced the launch of the first FDA-approved generic of Teva’s long-acting Copaxone .
The company has received an offer of about $2.17 billion for almost all of its over-the-counter drug business from France-based Cooper Consumer Health. Viatris will retain rights for erectile ...